Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahsan, A.
Right arrow Articles by Pasha, M. A. Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahsan, A.
Right arrow Articles by Pasha, M. A. Q.
(Chest. 2006;130:1511-1519.)
© 2006 American College of Chest Physicians

Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema*

Aarif Ahsan, MSc; Ghulam Mohd, MD; Tsering Norboo, MD; Masroor A. Baig, PhD and M. A. Qadar Pasha, PhD

* From the Functional Genomics Unit, Institute of Genomics and Integrative Biology (Mr. Ahsan and Dr. Qadar Pasha), Delhi; Department of Medicine, Sonam Norboo Memorial Hospital (Dr. Ghulam) Leh, Ladakh, J&K, India; Ladakh Heart Foundation and Ladakh Institute of Prevention, (Dr. Norboo) Leh, Ladakh, Jammu and Kashmir, India; and Department of Biochemistry (Dr. Baig) Hamdard University, New Delhi, India.

Correspondence to: M. A. Qadar Pasha, PhD, Functional Genomics Unit, Institute of Genomics and Integrative Biology, Mall Rd, Delhi-110 007, India; e-mail: qpasha{at}igib.res.in

Abstract

Study objectives: High-altitude pulmonary edema (HAPE), which develops on exertion under hypoxic conditions, aggravates due to endothelial dysfunction. Repeat events of the disorder suggests of genetic susceptibility. Endothelial nitric oxide synthase gene (NOS3), a regulator of vasodilation, has emerged as a strong candidate marker. In the present study, we investigated G894T, 27-base-pair 4b/4a (variable number of tandem repeat), –922A/G, and –786T/C polymorphisms of NOS3, individually or in combination, for an association with HAPE.

Design: A cross-sectional case control study.

Settings: Blood samples of HAPE-resistant lowlanders (HAPE-r) were obtained at sea level, and blood samples of patients with HAPE (HAPE-p) were obtained at Sonam Norboo Memorial Hospital, Leh, at 3,500 m.

Participants: The study groups consisted of 60 HAPE-r inducted two to three times to altitudes > 3,600 m; and 72 HAPE-p, who had HAPE on their first visit to high altitude.

Results: Nitrogen oxides (NOx) at 77.9 ± 28.6 µmol/L were significantly elevated in HAPE-r as compared to 42.39 ± 12.93 µmol/L in HAPE-p (p < 0.0001). Genotype distribution of G894T and 4b/4a polymorphisms was significantly different in the two groups (p = 0.001 and 0.009, respectively). Haplotype analysis revealed –922A/G and –786T/C polymorphisms in complete linkage disequilibrium. The wild-type haplotypes G-b (G894T, 4b/4a), G-A (G894T, –922A/G), and G-b-A (G894T, 4b/4a, –922A/G) were significantly overrepresented in HAPE-r (p < 0.0001, p = 0.03, and p = 0.02, respectively). The heterozygote genotype combination GTba as compared to wild-type combination GGbb was significantly higher in HAPE-p ({chi}2 = 18.62, p = 0.00009; odds ratio, 7.20; 95% confidence interval, 2.82 to 18.38). The combination of four heterozygotes GTbaAGTC was overrepresented in HAPE-p (p = 0.04), whereas the wild-type genotype combination GGbbAATT was overrepresented in HAPE-r (p = 0.002). Furthermore, the GGbb combination correlated with significantly elevated NOx as compared to remaining combinations as a whole in both HAPE-r and HAPE-p (p = 0.01 and 0.004, respectively).

Conclusions: Reduced NOx and combination of heterozygotes associate with the susceptibility to HAPE. The study impels another step toward application of NOx as a diagnostic marker for HAPE. The NOS3 GTba and GTbaAGTC genotype combinations may find application as genetic markers for predicting the risk for HAPE.

Key Words: genotype combination • high-altitude hypoxia • high-altitude pulmonary edema • nitric oxide • NOS3 polymorphisms







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.